Diets
ketogenic diet improves serious mental illness bipolar or schizophrenia
In plain terms: Can a ketogenic diet meaningfully improve bipolar disorder or schizophrenia?
Part of: 🥗 ketogenic diet
Early single-arm pilots show promising metabolic and symptom improvement, but no adequately-controlled RCT yet proves disorder-level efficacy, so the claim is plausible-but-unproven.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: ()
How the studies fall
What the evidence shows
Single-arm pilots are promising: a four-month study in 23 people with schizophrenia or bipolar disorder and metabolic abnormality reported a 32 percent fall in symptom scores alongside metabolic improvement. No adequately controlled trial has reported, the confirmatory protocol is still open, and process evaluation found high adherence burden and notable dropout.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Longhitano C, Finlay S, Peachey I, Swift JL, Fayet-Moore F, Bartle T, Vos G, Rudd D, Shareef O, Gordon S, Azghadi MR, Campbell I, Sethi S, Palmer C, Sarnyai Z 2024 · Frontiers in Nutrition | RCT | tested-null | low | RCT protocol only: states prior evidence is open-label/preclinical; confirmatory RCT not yet reported. |
| Sethi S, Wakeham D, Ketter T, Hooshmand F, Bjornstad J, Richards B, Westman E, Krauss RM, Saslow L 2024 · Psychiatry Research | observational | supports | moderate | 4-mo single-arm pilot (n=23) in schizophrenia/bipolar with metabolic abnormality: 32% BPRS drop in schizophrenia, 31% CGI improvement, metabolic syndrome resolved — uncontrolled, adjunctive, selected sample. |
| Bohnen JLB, Wigstrom TP, Griggs AM, Roytman S, Paalanen N, Andrews HA, Bohnen NI, Franklin JJH, McInnis MG 2023 · Nutrients | mechanism | mixed | low | Pilot trial protocol/rationale for a ketogenic-mimicking diet in bipolar disorder; preliminary framework rather than outcome evidence. |
| P Rigby B, Needham N, Grossi H, Kamenska I, H Campbell I, Meadowcroft B, Creasy F, Fisher C, Bahuguna P, Norrie J, Thompson G, C Gibbs M, Mitchell-Grigorjeva M, McLellan A, Moses T, Burgess K, Brown R, J Thrippleton M, Campbell H, J Smith D, A Simpson S 2025 · BMC Psychiatry | observational | mixed | low | Process evaluation of the pilot: adherence burden high, dropouts notable — feasibility caveats. |
| Ede G, Bernstein M, Calabrese L, Campbell IH, Laurent N, Palmer CM, Sethi S, Zupec-Kania B 2026 · Frontiers in Nutrition | observational | mixed | low | Delphi expert-consensus (Ede lead author) explicitly concedes evidence for treating mental illness has yet to mature. |
| Chaves C, Fabe J, Gomes FA, McNeely H, Tusconi M, Carta MG, Dursun SM, Hallak JEC, Brietzke E 2025 · Frontiers in pharmacology | observational | supports | low | Narrative review synthesizing case reports, small trials, and preclinical NMDA-antagonist animal models for ketogenic therapy in schizophrenia. States preliminary clinical findings (case reports, small trials) suggest symptom improvement bu |
| Newiss M 2025 · Frontiers in nutrition | n-of-1 | supports | low | Retrospective single case report of a carnivore ketogenic diet in one subject with schizophrenia, supported by a nutritional therapy practitioner. Reports remission, with glucose/ketone markers used to track dietary compliance. |
| Choi J, Kang J, Kim T, Nehs CJ 2024 · Frontiers in psychiatry | observational | supports | low | Narrative review linking sleep/oxidative stress mechanisms to bipolar disorder and schizophrenia, citing 'recent clinical trials' as suggesting positive symptom improvement from KD, while calling for further RCTs. |
| Chrysafi M, Jacovides C, Papadopoulou SK, Psara E, Vorvolakos T, Antonopoulou M, Dakanalis A, Martin M, Voulgaridou G, Pritsa A, Mentzelou M, Giaginis C 2024 · Nutrients | observational | supports | low | Comprehensive literature review of KD for stress/anxiety/depression/schizophrenia/bipolar disorder; animal studies consistently promising, but clinical human surveys described as 'moderate, usually not controlled,' with high dropout and het |
| Campbell IH, Needham N, Grossi H, Kamenska I, Luz S, Sheehan S, Thompson G, Thrippleton MJ, Gibbs MC, Leitao J, Moses T, Burgess K, Rigby BP, Simpson SA, McIntosh E, Brown R, Meadowcroft B, Creasy F, Mitchell-Grigorjeva M, Norrie J, McLellan A, Fisher C, Zieliński T, Gaggioni G, Campbell H, Smith DJ 2025 · BJPsych Open | observational | mixed | low | Same Edinburgh pilot cohort: metabolic and MRS (brain glutamate) changes; clinical signal modest, uncontrolled. |
| Palmer CM 2025 · BJPsych open | observational | supports | low | Editorial commentary discussing a study (Campbell et al) on feasibility/efficacy of KD in bipolar disorder and shared mechanisms across neuropsychiatric disorders. No independent primary data presented. |
| Janssen-Aguilar R, la Portilla JG, Martínez-Juárez IE, Mimiaga-Hernandez C, Alvarado-Luis G, Aguilar-Hernandez A, Garcia-Esparza KA, Hernadez-Palestina M, Crail-Meléndez D 2025 · Epilepsia Open | RCT | tested-null | low | Feasibility RCT found a modified Atkins (ketogenic) diet reduced psychogenic non-epileptic seizures and improved depression/anxiety, though not a psychotic/bipolar population. |
| Needham N, Campbell IH, Grossi H, Kamenska I, Rigby BP, Simpson SA, McIntosh E, Bahuguna P, Meadowcroft B, Creasy F, Mitchell-Grigorjeva M, Norrie J, Thompson G, Gibbs MC, McLellan A, Fisher C, Moses T, Burgess K, Brown R, Thrippleton MJ, Campbell H, Smith DJ 2023 · BJPsych Open | observational | tested-null | low | Open pilot in bipolar: feasible, signals in mood/energy — no control arm. |
| Rog J, Wingralek Z, Nowak K, Grudzień M, Grunwald A, Banaszek A, Karakula-Juchnowicz H 2024 · Journal of clinical medicine | observational | supports | low | Narrative review of KD in serious mental illness (bipolar, MDD, schizophrenia) noting evidence is 'predominantly case studies' suggesting reduced symptoms, weight loss, and improved metabolic markers, with very few clinical trials to date. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.